Transcriptomics

Dataset Information

0

Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset Pompe disease patient fibroblasts


ABSTRACT: human Pompe Disease (c.-32-13T>G) fibroblasts were exposed to 10 µM Deferoxamine (DFX) or 0.1% DMSO (control condition), for three days.

ORGANISM(S): Homo sapiens

PROVIDER: GSE155637 | GEO | 2021/01/19

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA650528 | ENA
2012-06-14 | GSE38680 | GEO
| S-EPMC7782201 | biostudies-literature
2016-10-11 | GSE82081 | GEO
2020-10-06 | GSE159063 | GEO
2017-04-11 | GSE75713 | GEO
2010-06-01 | GSE18976 | GEO
2017-05-13 | E-GEOD-57980 | biostudies-arrayexpress
2011-02-17 | E-GEOD-27280 | biostudies-arrayexpress
2017-05-13 | GSE57980 | GEO